Biblio Discovery — Demo Discovery Service

5 hasil untuk "Li-Xuan Qin"

Menampilkan 1–5 · 1,45 detik · RSS

  1. Artikel Jurnal Teks lengkap

    MicroRNA Array Normalization: An Evaluation Using a Randomized Dataset as the Benchmark

    Li-Xuan Qin; Qin Zhou

    PLoS ONE, Vol. 9 No. 6 · 2014 · Inggris · PLOS Scopus

    MicroRNA arrays possess a number of unique data features that challenge the assumption key to many normalization methods. We assessed the performance of existing normalization methods using two microRNA array datasets derived from the same set of tumor samples: one dataset was generated using a…

  2. Artikel Jurnal Teks lengkap

    Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis

    Timothy R. Gershon; Arash Shirazi; Li-Xuan Qin dkk.

    PLoS ONE, Vol. 4 No. 10 · 2009 · Inggris · PLOS Scopus

    Peripheral neuroblastic tumors (PNTs) share a common origin in the sympathetic nervous system, but manifest variable differentiation and growth potential. Malignant neuroblastoma (NB) and benign ganglioneuroma (GN) stand at opposite ends of the clinical spectrum. We hypothesize that a common PNT…

  3. Artikel Jurnal Teks lengkap

    Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer

    Hiromichi Ito; Qianxing Mo; Li-Xuan Qin dkk.

    PLoS ONE, Vol. 8 No. 12 · 2013 · Inggris · PLOS Scopus

    Purpose: The aim of this study was to build a molecular prognostic model based on gene signatures for patients with completely resected hepatic metastases from colorectal cancer (MCRC). Methods: Using the Illumina HumanHT-12 gene chip, RNA samples from the liver metastases of 96 patients who…

  4. Artikel Jurnal Teks lengkap

    A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

    Jordan M. Winter; Laura H. Tang; David S. Klimstra dkk.

    PLoS ONE, Vol. 7 No. 7 · 2012 · Inggris · PLOS Scopus

    Background: One–fifth of patients with seemingly ‘curable’ pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed ‘unresectable’ by conventional staging criteria…